ZA941958B - Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition - Google Patents
Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical compositionInfo
- Publication number
- ZA941958B ZA941958B ZA941958A ZA941958A ZA941958B ZA 941958 B ZA941958 B ZA 941958B ZA 941958 A ZA941958 A ZA 941958A ZA 941958 A ZA941958 A ZA 941958A ZA 941958 B ZA941958 B ZA 941958B
- Authority
- ZA
- South Africa
- Prior art keywords
- protein
- purification
- pharmaceutical composition
- reagent kit
- steptococcus
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 6
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 2
- 230000036039 immunity Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 102000018697 Membrane Proteins Human genes 0.000 title 1
- 108010052285 Membrane Proteins Proteins 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9300234 | 1993-03-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA941958B true ZA941958B (en) | 1995-01-27 |
Family
ID=20388669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA941958A ZA941958B (en) | 1993-03-19 | 1994-03-21 | Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5869064A (xx) |
| EP (1) | EP0656014B1 (xx) |
| JP (1) | JP3976334B2 (xx) |
| KR (1) | KR100331358B1 (xx) |
| CN (1) | CN1046291C (xx) |
| AT (1) | ATE240351T1 (xx) |
| CA (1) | CA2158658A1 (xx) |
| DE (1) | DE69432658T2 (xx) |
| DK (1) | DK0656014T3 (xx) |
| ES (1) | ES2194024T3 (xx) |
| HK (1) | HK1008825A1 (xx) |
| HU (1) | HU217582B (xx) |
| NZ (1) | NZ263275A (xx) |
| PT (1) | PT656014E (xx) |
| SG (1) | SG47049A1 (xx) |
| SI (1) | SI0656014T1 (xx) |
| WO (1) | WO1994021685A1 (xx) |
| ZA (1) | ZA941958B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015889A (en) | 1993-03-19 | 2000-01-18 | Gunnar Lindahl | Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| ES2540281T3 (es) | 1998-02-20 | 2015-07-09 | Id Biomedical Corporation Of Quebec | Antígenos de estreptococos del grupo B |
| HUP0201022A3 (en) * | 1998-12-22 | 2004-07-28 | Microscience Ltd Wokingham | Outer surface proteins, their genes, and their use |
| US6890539B2 (en) | 1998-12-22 | 2005-05-10 | Microscience, Ltd. | Genes and proteins, and their use |
| EP1757696A3 (en) * | 1998-12-22 | 2008-10-29 | Microscience Limited | Group B streptococcus proteins, and their use |
| TR200200633T2 (tr) * | 1998-12-23 | 2002-06-21 | Shire Biochem Inc. | Yeni streptococcus antijenleri |
| US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
| GB9910375D0 (en) | 1999-05-05 | 1999-06-30 | Lindahl Gunnar | Vaccine composition |
| EP1818402A3 (en) * | 2001-05-31 | 2008-04-02 | Fuso Pharmaceutical Industries, Ltd. | Method of evaluating the function of phagocyte and utilization thereof |
| WO2002099133A1 (fr) * | 2001-05-31 | 2002-12-12 | Fuso Pharmaceutical Industries, Ltd. | Procede ameliore de detection et d'identification de micro-organismes causes d'infections |
| CA2475821C (en) * | 2002-02-11 | 2011-12-13 | Shire Biochem Inc. | Group b streptococcus antigens |
| JP2008530021A (ja) * | 2005-02-08 | 2008-08-07 | アイディー バイオメディカル コーポレイション オブ ケベック シー．オー．ビー． アズ グラクソスミスクライン バイオロジカルズ ノース アメリカ | 医薬組成物 |
| ES2586418T3 (es) | 2007-04-16 | 2016-10-14 | Minervax Aps | Vacuna de proteína de fusión |
| CA3001433A1 (en) | 2015-10-21 | 2017-04-27 | Minervax Aps | Immunogenic fusion protein |
| US10888610B2 (en) | 2015-12-30 | 2021-01-12 | Minerv Ax Aps | Immunogenic complex for eliciting protective immunity against group b streptococcus |
| US20200254083A1 (en) | 2017-06-16 | 2020-08-13 | Glaxosmithkline Biologicals Sa | Method of treatment |
| CN114728051A (zh) | 2019-11-22 | 2022-07-08 | 葛兰素史克生物有限公司 | 细菌糖糖缀合物疫苗的剂量和施用 |
| EP4066854A1 (en) | 2021-03-29 | 2022-10-05 | MinervaX | Immunogenic fusion protein |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5302386A (en) * | 1986-04-16 | 1994-04-12 | Brigham And Women's Hospital, Inc. | Bacterial antigens, antibodies, vaccines and methods of manufacture |
| US4772584A (en) * | 1986-05-23 | 1988-09-20 | Cleary Paul P | Inhibitor of C5a-mediated chemotaxis |
| EP0367890A1 (en) * | 1988-11-11 | 1990-05-16 | HighTech Receptor AB | Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof |
| US5648241A (en) * | 1989-09-15 | 1997-07-15 | The General Hospital Corporation | Conjugate vaccine against group B streptococcus |
| IL95578A (en) * | 1989-09-15 | 1998-08-16 | Gen Hospital Corp | A vaccine made from polysaccharide and protein |
| JPH06506114A (ja) * | 1991-03-29 | 1994-07-14 | ファウルマン， エルビン | 新規な遺伝子及びＩｇＡ結合蛋白質の製造方法 |
-
1994
- 1994-03-21 CN CN94191519A patent/CN1046291C/zh not_active Expired - Fee Related
- 1994-03-21 JP JP52094694A patent/JP3976334B2/ja not_active Expired - Fee Related
- 1994-03-21 SI SI9430453T patent/SI0656014T1/xx unknown
- 1994-03-21 WO PCT/SE1994/000246 patent/WO1994021685A1/en active IP Right Grant
- 1994-03-21 AT AT94911348T patent/ATE240351T1/de not_active IP Right Cessation
- 1994-03-21 ES ES94911348T patent/ES2194024T3/es not_active Expired - Lifetime
- 1994-03-21 PT PT94911348T patent/PT656014E/pt unknown
- 1994-03-21 CA CA002158658A patent/CA2158658A1/en not_active Abandoned
- 1994-03-21 KR KR1019950703989A patent/KR100331358B1/ko not_active IP Right Cessation
- 1994-03-21 HU HU9501993A patent/HU217582B/hu not_active IP Right Cessation
- 1994-03-21 ZA ZA941958A patent/ZA941958B/xx unknown
- 1994-03-21 DK DK94911348T patent/DK0656014T3/da active
- 1994-03-21 DE DE69432658T patent/DE69432658T2/de not_active Expired - Lifetime
- 1994-03-21 NZ NZ263275A patent/NZ263275A/en not_active IP Right Cessation
- 1994-03-21 SG SG1996004387A patent/SG47049A1/en unknown
- 1994-03-21 EP EP94911348A patent/EP0656014B1/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/487,675 patent/US5869064A/en not_active Expired - Fee Related
-
1998
- 1998-07-29 HK HK98109536A patent/HK1008825A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100331358B1 (ko) | 2002-08-13 |
| DE69432658D1 (de) | 2003-06-18 |
| AU681130B2 (en) | 1997-08-21 |
| ES2194024T3 (es) | 2003-11-16 |
| HUT72841A (en) | 1996-05-28 |
| DE69432658T2 (de) | 2004-04-08 |
| SG47049A1 (en) | 1998-03-20 |
| ATE240351T1 (de) | 2003-05-15 |
| KR960701096A (ko) | 1996-02-24 |
| EP0656014B1 (en) | 2003-05-14 |
| JPH09500092A (ja) | 1997-01-07 |
| US5869064A (en) | 1999-02-09 |
| AU6389194A (en) | 1994-10-11 |
| HU217582B (hu) | 2000-02-28 |
| DK0656014T3 (da) | 2003-08-11 |
| CA2158658A1 (en) | 1994-09-29 |
| PT656014E (pt) | 2003-09-30 |
| SI0656014T1 (en) | 2003-12-31 |
| CN1046291C (zh) | 1999-11-10 |
| CN1119442A (zh) | 1996-03-27 |
| JP3976334B2 (ja) | 2007-09-19 |
| WO1994021685A1 (en) | 1994-09-29 |
| HK1008825A1 (en) | 1999-05-21 |
| HU9501993D0 (en) | 1995-08-28 |
| EP0656014A1 (en) | 1995-06-07 |
| NZ263275A (en) | 1997-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA941958B (en) | Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition | |
| ES8504460A1 (es) | Procedimiento para producir la totalidad o parte de las subunidades a y b de la toxina del colera | |
| DE3783191D1 (de) | Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g. | |
| AU1672388A (en) | Expression of human proapolipoprotein a-i | |
| AU1026692A (en) | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same | |
| ATE323721T1 (de) | Cholin-bindendes protein, welches als gegen pneumokokken gerichtetes vakzin verwendet wird | |
| NO20006191L (no) | Vaksine | |
| ZA859437B (en) | Dna sequence encoding a hirudin-like protein and process for preparing such protein | |
| NZ296748A (en) | Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods | |
| GR3034766T3 (en) | Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections. | |
| WO1999015666A3 (en) | Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof | |
| AU8127494A (en) | Chimeric proteins comprising borrelia polypeptides: uses therefor | |
| EP0554389A4 (en) | Molecular clones of hiv-1 and uses thereof | |
| MX9606463A (es) | Secuencias de nucleotido de las cepas pestivirus, polipeptidos codificados por estas secuencias y usos de los mismos para la diagnosis y prevencion de infecciones con pestivirus. | |
| NZ500540A (en) | Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae | |
| GB9814538D0 (en) | Helicobacter pylori bacterioferritin | |
| GB9409985D0 (en) | Vaccine against mycobacterial infections | |
| AU6745287A (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
| NO177570B (no) | Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper | |
| WO1996008569A3 (en) | Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof | |
| Schmidt et al. | Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF | |
| BR9908476A (pt) | Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae | |
| NZ233672A (en) | Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence | |
| AU1540795A (en) | Diagnosis and treatment of infections due to streptococci and enterococci | |
| SE9301207D0 (sv) | Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |